Acer Therapeutics Announces FDA Acceptance of NDA and Priority Review for EDSIVO™ for the Treatment of vEDS - Associated Press https://t.co/wJKNqWwEIN
— IDRO (@IDROOhio) December 26, 2018
from Twitter https://twitter.com/IDROOhio
December 26, 2018 at 07:17AM
No comments:
Post a Comment